Spyre Therapeutics, Inc 10-Q for FY2022 Q3
Spyre Therapeutics, Inc. (SYRE)
10-Q
2022-11-03
For: 2022-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Spyre Therapeutics, Inc filed this 10-Q on November 3, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $174K
- down 87.6% from $1.4M a year earlier
- Net loss
- $18.23M
- compared with a net loss of $20.31M a year earlier
- Diluted EPS
- -$0.19
- compared with -$0.31 a year earlier